569 related articles for article (PubMed ID: 29049014)
21. Computational drug repositioning: from data to therapeutics.
Hurle MR; Yang L; Xie Q; Rajpal DK; Sanseau P; Agarwal P
Clin Pharmacol Ther; 2013 Apr; 93(4):335-41. PubMed ID: 23443757
[TBL] [Abstract][Full Text] [Related]
22. Drug Repositioning to Accelerate Drug Development Using Social Media Data: Computational Study on Parkinson Disease.
Zhao M; Yang CC
J Med Internet Res; 2018 Oct; 20(10):e271. PubMed ID: 30309833
[TBL] [Abstract][Full Text] [Related]
23. Computational Prediction of Drug-Target Interactions via Ensemble Learning.
Ezzat A; Wu M; Li X; Kwoh CK
Methods Mol Biol; 2019; 1903():239-254. PubMed ID: 30547446
[TBL] [Abstract][Full Text] [Related]
24. Drug repurposing: a promising tool to accelerate the drug discovery process.
Parvathaneni V; Kulkarni NS; Muth A; Gupta V
Drug Discov Today; 2019 Oct; 24(10):2076-2085. PubMed ID: 31238113
[TBL] [Abstract][Full Text] [Related]
25. PS4DR: a multimodal workflow for identification and prioritization of drugs based on pathway signatures.
Emon MA; Domingo-Fernández D; Hoyt CT; Hofmann-Apitius M
BMC Bioinformatics; 2020 Jun; 21(1):231. PubMed ID: 32503412
[TBL] [Abstract][Full Text] [Related]
26. From drug repositioning to target repositioning: prediction of therapeutic targets using genetically perturbed transcriptomic signatures.
Namba S; Iwata M; Yamanishi Y
Bioinformatics; 2022 Jun; 38(Suppl 1):i68-i76. PubMed ID: 35758779
[TBL] [Abstract][Full Text] [Related]
27. An update on Drug Repurposing: Re-written saga of the drug's fate.
Gns HS; Gr S; Murahari M; Krishnamurthy M
Biomed Pharmacother; 2019 Feb; 110():700-716. PubMed ID: 30553197
[TBL] [Abstract][Full Text] [Related]
28. Network-based drug ranking and repositioning with respect to DrugBank therapeutic categories.
Re M; Valentini G
IEEE/ACM Trans Comput Biol Bioinform; 2013; 10(6):1359-71. PubMed ID: 24407295
[TBL] [Abstract][Full Text] [Related]
29. DeSigN: connecting gene expression with therapeutics for drug repurposing and development.
Lee BK; Tiong KH; Chang JK; Liew CS; Abdul Rahman ZA; Tan AC; Khang TF; Cheong SC
BMC Genomics; 2017 Jan; 18(Suppl 1):934. PubMed ID: 28198666
[TBL] [Abstract][Full Text] [Related]
30. DrugNet: network-based drug-disease prioritization by integrating heterogeneous data.
Martínez V; Navarro C; Cano C; Fajardo W; Blanco A
Artif Intell Med; 2015 Jan; 63(1):41-9. PubMed ID: 25704113
[TBL] [Abstract][Full Text] [Related]
31. A miRNA-driven inference model to construct potential drug-disease associations for drug repositioning.
Chen H; Zhang Z
Biomed Res Int; 2015; 2015():406463. PubMed ID: 25789319
[TBL] [Abstract][Full Text] [Related]
32. Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System.
Regan K; Moosavinasab S; Payne P; Lin S
J Vis Exp; 2016 Dec; (118):. PubMed ID: 28060329
[TBL] [Abstract][Full Text] [Related]
33. DMAP: a connectivity map database to enable identification of novel drug repositioning candidates.
Huang H; Nguyen T; Ibrahim S; Shantharam S; Yue Z; Chen JY
BMC Bioinformatics; 2015; 16 Suppl 13(Suppl 13):S4. PubMed ID: 26423722
[TBL] [Abstract][Full Text] [Related]
34. Prediction of drugs having opposite effects on disease genes in a directed network.
Yu H; Choo S; Park J; Jung J; Kang Y; Lee D
BMC Syst Biol; 2016 Jan; 10 Suppl 1(Suppl 1):2. PubMed ID: 26818006
[TBL] [Abstract][Full Text] [Related]
35. Repurposed Drugs as Potential Therapeutic Candidates for the Management of Alzheimer's Disease.
Shoaib M; Kamal MA; Rizvi SMD
Curr Drug Metab; 2017; 18(9):842-852. PubMed ID: 28595531
[TBL] [Abstract][Full Text] [Related]
36. Computational drug repositioning through heterogeneous network clustering.
Wu C; Gudivada RC; Aronow BJ; Jegga AG
BMC Syst Biol; 2013; 7 Suppl 5(Suppl 5):S6. PubMed ID: 24564976
[TBL] [Abstract][Full Text] [Related]
37. Drug repositioning in SLE: crowd-sourcing, literature-mining and Big Data analysis.
Grammer AC; Ryals MM; Heuer SE; Robl RD; Madamanchi S; Davis LS; Lauwerys B; Catalina MD; Lipsky PE
Lupus; 2016 Sep; 25(10):1150-70. PubMed ID: 27497259
[TBL] [Abstract][Full Text] [Related]
38. NFFinder: an online bioinformatics tool for searching similar transcriptomics experiments in the context of drug repositioning.
Setoain J; Franch M; Martínez M; Tabas-Madrid D; Sorzano CO; Bakker A; Gonzalez-Couto E; Elvira J; Pascual-Montano A
Nucleic Acids Res; 2015 Jul; 43(W1):W193-9. PubMed ID: 25940629
[TBL] [Abstract][Full Text] [Related]
39. Systems biology based drug repositioning for development of cancer therapy.
Turanli B; Altay O; Borén J; Turkez H; Nielsen J; Uhlen M; Arga KY; Mardinoglu A
Semin Cancer Biol; 2021 Jan; 68():47-58. PubMed ID: 31568815
[TBL] [Abstract][Full Text] [Related]
40. In silico drug repositioning: from large-scale transcriptome data to therapeutics.
Kwon OS; Kim W; Cha HJ; Lee H
Arch Pharm Res; 2019 Oct; 42(10):879-889. PubMed ID: 31482491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
